Get the latest Venture Capital & Angel investors news and info Join Our Mailing List:

Your Name: 

Your Email:  

*By submitting your name & email you agree to receive for FREE our scholarships & offers Newsletters. You agree also with the storage and handling of your data by this website and 3rd party email services.
You may unsubscribe if you wish. And you can delete your email and name at any time by emailing us to the email on the bottom of this page.

Follow us on
 
  • Sadra Medical Raises $19 Million in Series B Financing

    October 24th, 2006 No comments

    Sadra Medical, a privately-held, development stage Silicon Valley firm dedicated to developing innovative new therapies for aortic valve disease, has recently completed a $19 Million Series B round of funding. Oakwood Medical Investors and Boston Scientific joined the company’s Series A investors, Pequot Ventures, Onset Ventures and SV Life Sciences Advisors (SVLS), in the financing.

    “We are pleased to be backed by the deep experience base of our investors. Their support will help us in attaining our goal of delivering the best device possible to make percutaneous aortic valve replacement a viable therapeutic option for patients in need,” stated Amr Salahieh, President and CEO of Sadra Medical. “Our momentum is building and we look forward to initiating clinical evaluation of the Sadra Lotusā„¢ Valve within the next several months.”

    Raul Perez, president of Oakwood Medical, observed, “We believe percutaneous aortic valve replacement will play a significant therapeutic role in the future. This investment in Sadra Medical reflects the consensus of the group of investors that the innovativeĀ second-generation repositionable Lotus prosthesis developed by Sadra has great potential.”

    Treatment of aortic valve disease remains a significant and growing unmet clinical need. As many as 3 million people in the U.S. have aortic stenosis; however, only a small percentage of those are treated with the current standard of care, open-heart valve replacement surgery, using cardiopulmonary bypass. By delivering a highly effective aortic valve replacement that reduces the risks and morbidity associated with surgery, Sadra Medical seeks to provide a therapeutic option for patients who are not being treated today.

    Amr Salahieh and a small group of leading-edge cardiovascular clinicians founded Sadra Medical in 2003. Board members include Salahieh, Leslie Bottorff of Onset Ventures, Juliet Tammenoms Bakker of Pequot Ventures, David Milne of SVLS, and Fred Khosravi, CEO of Access Closure.

Leave a reply

Please leave these two fields as-is:

Protected by Invisible Defender. Showed 403 to 253,353 bad guys.

 

Latest Headlines:

Friday August 31, 2012
Zscaler Secures $38 Million Investment Round


Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.


Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects


Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding


Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies


Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains


Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster


Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility


 

By using this website you agree with our cookie policy